Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.25
Bid: 15.00
Ask: 15.50
Change: -0.50 (-3.23%)
Spread: 0.50 (3.333%)
Open: 15.00
High: 15.50
Low: 14.65
Prev. Close: 15.50
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Australia's AGL says approached by Alinta to buy coal-fired Liddell plant

Wed, 04th Apr 2018 03:02

* No formal offer received - AGL

* Liddell slated to be closed in 2022

* Australia government sought Alinta's interest(Adds fresh Alinta MD quote, background)

SYDNEY, April 4 (Reuters) - Australia's biggest energyproducer AGL Energy Ltd said on Wednesday HongKong-owned rival Alinta Energy has expressed interest in buyingits coal-fired Liddell Power Station, which is slated to beclosed.

AGL wants to shutter the plant in 2022 as part of a phasedexit from coal by 2050 so it can become a purely renewableenergy supplier. But the firm has come under pressure fromAustralia's government to sell the power station instead.

AGL said it received "an approach from Alinta last nightexpressing an interest in entering negotiations" to buy theplant, but that no formal bid had been made.

A formal offer "would be given consideration in order tomeet our obligations to customers and shareholders," AGL said inan emailed statement.

Australia's electricity supply business has become a hotpolitical issue in the past year, after a string of blackoutsand price spikes hit households and major industrial usersincluding miners BHP and Rio Tinto.

That has prompted the country's conservative government toscrap some subsidies for renewable projects. This week abreakaway group of lawmakers called for the government toprovide more financial support for new coal-fired plants.

Alinta's Managing Director Jeff Dimery said in a radiointerview on Wednesday that the government had asked hiscompany, which is owned by Hong Kong's Chow Tai Fook EnterprisesLtd, to consider buying Liddell.

"We stated that we had no objection to owning criticalassets required for stability and reliability in the marketplaceas we transition to a low-carbon economy," Dimery toldAustralian Broadcasting Corp radio.

"We conducted some preliminary analysis that led us to anopinion that, at a commercial rate, there's an opportunityhere," he added.

AGL previously rejected the idea of selling the plantbecause it needs Liddell, located north of Sydney, to maintainsupplies to its own customers ahead of the original 2022 closureplan.

"AGL is relying on Liddell to generate power for ourcustomers until 2022 and we will require its infrastructure forour replacement plans into the future," it said on Wednesday.(Reporting by Tom Westbrook in SYDNEY Additional reporting bySumeet Gaikwad in BENGALURUEditing by Byron Kaye and Aaron Sheldrick)

More News
31 Mar 2020 09:40

Angle UK, US, Canada operations 'severely disrupted' by Covid-19

(Sharecast News) - Liquid biopsy company Angle said on Tuesday that operations in the UK, US and Canada had all been "severely disrupted" by the Covid-19 pandemic.

Read more
3 Mar 2020 18:58

Angle Parsortix Test Used To Help Discover Brain Metastasis

Angle Parsortix Test Used To Help Discover Brain Metastasis

Read more
27 Feb 2020 14:09

Angle's Parsortix Beats Others In Assessing Kidney Cancer Patients

Angle's Parsortix Beats Others In Assessing Kidney Cancer Patients

Read more
27 Feb 2020 12:42

Angle upbeat on recent Parsortix research out of Italy

(Sharecast News) - Liquid biopsy company Angle announced on Thursday that Istituto Nazionale Tumori di Milano in Milan, Italy, has published results of work assessing the performance of its 'Parsortix' system in renal cell carcinoma (RCC), demonstrating key advantages of Parsortix.

Read more
17 Feb 2020 15:25

Angle upbeat on German research into 'Parsortix'

(Sharecast News) - Liquid biopsy company Angle announced on Monday that University Medical Centre Hamburg-Eppendorf has published results of work undertaken to assess the analytical and clinical performance of 'Parsortix' in multiple metastatic cancer types, with the main emphasis on metastatic breast cancer.

Read more
11 Feb 2020 10:51

Study Finds Angle's Parsortix Can Predict Melanoma Sufferers Survival

Study Finds Angle's Parsortix Can Predict Melanoma Sufferers Survival

Read more
11 Feb 2020 07:41

Angle upbeat on research into Parsortix with melanoma patients

(Sharecast News) - Liquid biopsy company Angle announced on Tuesday that a customer, the Edith Cowan University in Perth, Western Australia, has published results of research into the use of its 'Parsortix' system with melanoma patients.

Read more
30 Jan 2020 11:41

Angle Loss Widens As It Eyes US Parsotix Cancer Treatment Clearance

Angle Loss Widens As It Eyes US Parsotix Cancer Treatment Clearance

Read more
23 Jan 2020 16:10

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
22 Jan 2020 11:00

Angle Eyes US Consent For Parsortix Cancer Medication In Third Quarter

Angle Eyes US Consent For Parsortix Cancer Medication In Third Quarter

Read more
7 Nov 2019 13:50

Angle Gets Study Results Demonstrating Use Of Parsortix In Melanoma

Angle Gets Study Results Demonstrating Use Of Parsortix In Melanoma

Read more
31 Oct 2019 15:38

Angle Submits Positive Test Results For Parsortix System To US FDA

Angle Submits Positive Test Results For Parsortix System To US FDA

Read more
4 Oct 2019 15:17

Angle upbeat on patent grant for prostate cancer blood assessment

(Sharecast News) - Liquid biopsy company Angle announced on Friday that the Queen Mary University of London (QMUL) European patent covering the measurement of the number of megakaryocytes in a patient blood sample as an assessment of the prognosis for prostate cancer has been granted.

Read more
4 Oct 2019 08:58

Angle Notes Queen Mary University's European Cancer Prognosis Patent

Angle Notes Queen Mary University's European Cancer Prognosis Patent

Read more
4 Sep 2019 14:09

Angle Reports Positive Study Results For Parsortix System

(Alliance News) - Angle PLC on Wednesday noted positive results from a study of its Parsortix system in small cell lung cancer.Parsortix is Angle's liquid biopsy technology, meaning it

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.